Erythropoietin protects against murine cerebral malaria through actions on host cellular immunity

Infection and Immunity

Volumn 82, Issue 1, 2014, Pages 165-173

  Wei, Xu ^a   Li, Ying ^a   Sun, Xiaodan ^a   Zhu, Xiaotong ^a   Feng, Yonghui ^a   Liu, Jun ^a   Jiang, Yongjun ^a   Shang, Hong ^a   Cui, Liwang ^b   Cao, Yaming ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MONOCLONAL ANTIBODY; NITRIC OXIDE; POLYCLONAL ANTIBODY; RECOMBINANT ERYTHROPOIETIN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN BLOOD VESSEL; BRAIN MALARIA; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; ERYTHROCYTE; EXPERIMENTAL INFECTION; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HOST CELL; HOST PARASITE INTERACTION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INNATE IMMUNITY; MALARIA; MICROVASCULATURE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

EID: 84890848421     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00929-13     Document Type: Article

References (63)

1. van der Heyde HC, Nolan J, Combes V, Gramaglia I, Grau GE. 2006. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 22:503-508. http://dx.doi.org/10.1016/j.pt.2006.09.002.
2. Krantz SB. 1991. Erythropoietin. Blood 77:419-434.
3. Brines M, Cerami A. 2005. Emerging biological roles for erythropoietin in the nervous system. Nat. Rev. Neurosci. 6:484-494. http://dx.doi.org/10.1038/nrn1687.
4. Arcasoy MO. 2008. The non-haematopoietic biological effects of erythropoietin. Br. J. Haematol. 141:14-31. http://dx.doi.org/10.1111/j.1365-2141.2008.07014.x.
5. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, Sasaki R. 1998. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. U.S.A. 95:4635-4640. http://dx.doi.org/10.1073/pnas.95.8.4635.
6. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A. 2000. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. U.S.A. 97:10526-10531. http://dx.doi.org/10.1073/pnas.97.19.10526.
7. Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, Fratelli M, Latini R, Xie QW, Smart J, Su-Rick CJ, Pobre E, Diaz D, Gomez D, Hand C, Coleman T, Cerami A. 2004. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc. Natl. Acad. Sci. U.S.A. 101:14907-14912. http://dx.doi.org/10.1073/pnas.0406491101.
8. D'Andrea RJ, Gonda TJ. 2000. A model for assembly and activation of the GM-CSF, IL-3 and IL-5 receptors: insights from activated mutants of the common beta subunit. Exp. Hematol. 28:231-243. http://dx.doi.org/10.1016/S0301-472X(99)00159-9.
9. Brines M, Cerami A. 2006. Discovering erythropoietin's extrahematopoietic functions: biology and clinical promise. Kidney Int. 70: 246-250. http://dx.doi.org/10.1038/sj.ki.5001546.
10. Yuan R, Maeda Y, Li W, Lu W, Cook S, Dowling P. 2008. Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE. PLoS One 3:e1924. http://dx.doi.org/10.1371/journal.pone.0001924.
11. Agnello D, Bigini P, Villa P, Mennini T, Cerami A, Brines ML, Ghezzi P. 2002. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res. 952: 128-134. http://dx.doi.org/10.1016/S0006-8993(02)03239-0.
12. Li W, Maeda Y, Yuan RR, Elkabes S, Cook S, Dowling P. 2004. Beneficial effect of erythropoietin on experimental allergic encephalomyelitis. Ann. Neurol. 56:767-777. http://dx.doi.org/10.1002/ana.20274.
13. Chen SJ, Wang YL, Lo WT, Wu CC, Hsieh CW, Huang CF, Lan YH, Wang CC, Chang DM, Sytwu HK. 2010. Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 162:210-223. http://dx.doi.org/10.1111/j.1365-2249.2010.04238.x.
14. Nairz M, Schroll A, Moschen AR, Sonnweber T, Theurl M, Theurl I, Taub N, Jamnig C, Neurauter D, Huber LA, Tilg H, Moser PL, Weiss G. 2011. Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-kappaB-inducible immune pathways. Immunity 34:61-74. http://dx.doi.org/10.1016/j.immuni.2011.01.002.
15. Mittelman M, Neumann D, Peled A, Kanter P, Haran-Ghera N. 2001. Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models. Proc. Natl. Acad. Sci. U.S.A. 98: 5181-5186. http://dx.doi.org/10.1073/pnas.081275298.
16. Prutchi-Sagiv S, Golishevsky N, Oster HS, Katz O, Cohen A, Naparstek E, Neumann D, Mittelman M. 2006. Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease? Br. J. Haematol. 135:660-672. http://dx.doi.org/10.1111/j.1365-2141.2006.06366.x.
17. Katz O, Gil L, Lifshitz L, Prutchi-Sagiv S, Gassmann M, Mittelman M, Neumann D. 2007. Erythropoietin enhances immune responses in mice. Eur. J. Immunol. 37:1584-1593. http://dx.doi.org/10.1002/eji.200637025.
18. Prutchi Sagiv S, Lifshitz L, Orkin R, Mittelman M, Neumann D. 2008. Erythropoietin effects on dendritic cells: potential mediators in its function as an immunomodulator? Exp. Hematol. 36:1682-1690. http://dx.doi.org/10.1016/j.exphem.2008.07.010.
19. Lifshitz L, Prutchi-Sagiv S, Avneon M, Gassmann M, Mittelman M, Neumann D. 2009. Non-erythroid activities of erythropoietin: Functional effects on murine dendritic cells. Mol. Immunol. 46:713-721. http://dx.doi.org/10.1016/j.molimm.2008.10.004.
20. Newton CR, Warn PA, Winstanley PA, Peshu N, Snow RW, Pasvol G, Marsh K. 1997. Severe anaemia in children living in a malaria endemic area of Kenya. Trop. Med. Int. Health 2:165-178. http://dx.doi.org/10.1046/j.1365-3156.1997.d01-238.x.
21. Kurtzhals JA, Rodrigues O, Addae M, Commey JO, Nkrumah FK, Hviid L. 1997. Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria. Br. J. Haematol. 97:169-174. http://dx.doi.org/10.1046/j.1365-2141.1997.82654.x.
22. Casals-Pascual C, Kai O, Cheung JO, Williams S, Lowe B, Nyanoti M, Williams TN, Maitland K, Molyneux M, Newton CR, Peshu N, Watt SM, Roberts DJ. 2006. Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo. Blood 108:2569-2577. http://dx.doi.org/10.1182/blood-2006-05-018697.
23. Casals-Pascual C, Idro R, Gicheru N, Gwer S, Kitsao B, Gitau E, Mwakesi R, Roberts DJ, Newton CR. 2008. High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria. Proc. Natl. Acad. Sci. U.S.A. 105:2634-2639. http://dx.doi.org/10.1073/pnas.0709715105.
24. Kaiser K, Texier A, Ferrandiz J, Buguet A, Meiller A, Latour C, Peyron F, Cespuglio R, Picot S. 2006. Recombinant human erythropoietin prevents the death of mice during cerebral malaria. J. Infect. Dis. 193:987-995. http://dx.doi.org/10.1086/500844.
25. Wiese L, Hempel C, Penkowa M, Kirkby N, Kurtzhals JA. 2008. Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria. Malar. J. 7:3. http://dx.doi.org/10.1186/1475-2875-7-3.
26. Core A, Hempel C, Kurtzhals JA, Penkowa M. 2011. Plasmodium berghei ANKA: erythropoietin activates neural stem cells in an experimental cerebral malaria model. Exp. Parasitol. 127:500-505. http://dx.doi.org/10.1016/j.exppara.2010.09.010.
27. Marti HH. 2004. Erythropoietin and the hypoxic brain. J. Exp. Biol. 207: 3233-3242. http://dx.doi.org/10.1242/jeb.01049.
28. Hempel C, Combes V, Hunt NH, Kurtzhals JA, Grau GE. 2011. CNS hypoxia is more pronounced in murine cerebral than noncerebral malaria and is reversed by erythropoietin. Am. J. Pathol. 179:1939-1950. http://dx.doi.org/10.1016/j.ajpath.2011.06.027.
29. Yamakuchi M, Kirkiles-Smith NC, Ferlito M, Cameron SJ, Bao C, Fox-Talbot K, Wasowska BA, Baldwin WM, III, Pober JS, Lowenstein CJ. 2007. Antibody to human leukocyte antigen triggers endothelial exocytosis. Proc. Natl. Acad. Sci. U.S.A. 104:1301-1306. http://dx.doi.org/10.1073/pnas.0602035104.
30. Belayev L, Busto R, Zhao W, Ginsberg MD. 1996. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res. 739:88-96. http://dx.doi.org/10.1016/S0006-8993(96)00815-3.
31. Gramaglia I, Sobolewski P, Meays D, Contreras R, Nolan JP, Frangos JA, Intaglietta M, van der Heyde HC. 2006. Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat. Med. 12:1417-1422. http://dx.doi.org/10.1038/nm1499.
32. Chen G, Liu J, Wang QH, Wu Y, Feng H, Zheng W, Guo SY, Li DM, Wang JC, Cao YM. 2009. Effects of CD4(+)CD25(+)Foxp3(+) regulatory T cells on early Plasmodium yoelii 17XL infection in BALB/c mice. Parasitology 136:1107-1120. http://dx.doi.org/10.1017/S0031182009990370.
33. Cao Y, Tsuboi T, Torii M. 1998. Nitric oxide inhibits the development of Plasmodium yoelii gametocytes into gametes. Parasitol. Int. 47:157-166. http://dx.doi.org/10.1016/S1383-5769(98)00014-2.
34. Zheng W, Wang QH, Feng H, Liu J, Meng HR, Cao YM. 2009. CD4+CD25+Foxp3+regulatory T cells prevent the development of Th1 immune response by inhibition of dendritic cell function during the early stage of Plasmodium yoelii infection in susceptible BALB/c mice. Folia Parasitol. 56:242-250.
35. Renia L, Wu HS, Claser C, Charlotte Gruner A, Suwanarusk R, Hui Teo T, Russell B, Ng LF. 2012. Cerebral malaria: mysteries at the blood-brain barrier. Virulence 3:193-201. http://dx.doi.org/10.4161/viru.19013.
36. Medana IM, Turner GD. 2006. Human cerebral malaria and the bloodbrain barrier. Int. J. Parasitol. 36:555-568. http://dx.doi.org/10.1016/j.ijpara.2006.02.004.
37. Favre N, Da Laperousaz C, Ryffel B, Weiss NA, Imhof BA, Rudin W, Lucas R, Piguet PF. 1999. Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect. 1:961-968. http://dx.doi.org/10.1016/S1286-4579(99)80513-9.
38. Bauer PR, Van Der Heyde HC, Sun G, Specian RD, Granger DN. 2002. Regulation of endothelial cell adhesion molecule expression in an experimental model of cerebral malaria. Microcirculation 9:463-470. http://dx.doi.org/10.1038/sj.mn.7800159.
39. de Kossodo S, Grau GE. 1993. Role of cytokines and adhesion molecules in malaria immunopathology. Stem Cells 11:41-48. http://dx.doi.org/10.1002/stem.5530110108.
40. Lifshitz L, Tabak G, Gassmann M, Mittelman M, Neumann D. 2010. Macrophages as novel target cells for erythropoietin. Haematologica 95: 1823-1831. http://dx.doi.org/10.3324/haematol.2010.025015.
41. Yanez DM, Manning DD, Cooley AJ, Weidanz WP, van der Heyde HC. 1996. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J. Immunol. 157:1620-1624.
42. Hansen DS, Schofield L. 2010. Natural regulatory T cells in malaria: host or parasite allies? PLoS Pathog. 6:e1000771. http://dx.doi.org/10.1371/journal.ppat.1000771.
43. Haque A, Best SE, Amante FH, Mustafah S, Desbarrieres L, de Labastida F, Sparwasser T, Hill GR, Engwerda CR. 2010. CD4+ natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo. PLoS Pathog. 6:e1001221. http://dx.doi.org/10.1371/journal.ppat.1001221.
44. Dodoo D, Omer FM, Todd J, Akanmori BD, Koram KA, Riley EM. 2002. Absolute levels and ratios of proinflammatory and antiinflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J. Infect. Dis. 185:971-979. http://dx.doi.org/10.1086/339408.
45. Villegas-Mendez A, Greig R, Shaw TN, de Souza JB, Gwyer Findlay E, Stumhofer JS, Hafalla JC, Blount DG, Hunter CA, Riley EM, Couper KN. 2012. IFN-gamma-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain. J. Immunol. 189:968-979. http://dx.doi.org/10.4049/jimmunol.1200688.
46. Belnoue E, Kayibanda M, Vigario AM, Deschemin JC, van Rooijen N, Viguier M, Snounou G, Renia L. 2002. On the pathogenic role of brainsequestered alphabeta CD8+ T cells in experimental cerebral malaria. J. Immunol. 169:6369-6375.
47. McQuillan JA, Mitchell AJ, Ho YF, Combes V, Ball HJ, Golenser J, Grau GE, Hunt NH. 2011. Coincident parasite and CD8 T cell sequestration is required for development of experimental cerebral malaria. Int. J. Parasitol. 41:155-163. http://dx.doi.org/10.1016/j.ijpara.2010.08.003.
48. deWalick S, Amante FH, McSweeney KA, Randall LM, Stanley AC, Haque A, Kuns RD, MacDonald KP, Hill GR, Engwerda CR. 2007. Cutting edge: conventional dendritic cells are the critical APC required for the induction of experimental cerebral malaria. J. Immunol. 178:6033-6037.
49. Lundie RJ, de Koning-Ward TF, Davey GM, Nie CQ, Hansen DS, Lau LS, Mintern JD, Belz GT, Schofield L, Carbone FR, Villadangos JA, Crabb BS, Heath WR. 2008. Blood-stage Plasmodium infection induces CD8+T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha+ dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 105:14509-14514. http://dx.doi.org/10.1073/pnas.0806727105.
50. Nie CQ, Bernard NJ, Schofield L, Hansen DS. 2007. CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis. Infect. Immun. 75:2275-2282. http://dx.doi.org/10.1128/IAI.01783-06.
51. Freitas do Rosario AP, Langhorne J. 2012. T cell-derived IL-10 and its impact on the regulation of host responses during malaria. Int. J. Parasitol. 42:549-555. http://dx.doi.org/10.1016/j.ijpara.2012.03.010.
52. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392:245-252. http://dx.doi.org/10.1038/32588.
53. Ing R, Segura M, Thawani N, Tam M, Stevenson MM. 2006. Interaction of mouse dendritic cells and malaria-infected erythrocytes: uptake, maturation, and antigen presentation. J. Immunol. 176:441-450.
54. Pouniotis DS, Proudfoot O, Bogdanoska V, Scalzo K, Kovacevic S, Coppel RL, Plebanski M. 2005. Selectively impaired CD8+ but not CD4+T cell cycle arrest during priming as a consequence of dendritic cell interaction with plasmodium-infected red cells. J. Immunol. 175:3525-3533.
55. Shortman K, Liu YJ. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151-161. http://dx.doi.org/10.1038/nri746.
56. Liu YJ. 2001. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106:259-262. http://dx.doi.org/10.1016/S0092-8674(01)00456-1.
57. Jangpatarapongsa K, Chootong P, Sattabongkot J, Chotivanich K, Sirichaisinthop J, Tungpradabkul S, Hisaeda H, Troye-Blomberg M, Cui L, Udomsangpetch R. 2008. Plasmodium vivax parasites alter the balance of myeloid and plasmacytoid dendritic cells and the induction of regulatory T cells. Eur. J. Immunol. 38:2697-2705. http://dx.doi.org/10.1002/eji.200838186.
58. Trinchieri G, Sher A. 2007. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 7:179-190. http://dx.doi.org/10.1038/nri2038.
59. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:621-667. http://dx.doi.org/10.1146/annurev.immunol.20.100301.064828.
60. Krishnegowda G, Hajjar AM, Zhu J, Douglass EJ, Uematsu S, Akira S, Woods AS, Gowda DC. 2005. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J. Biol. Chem. 280: 8606-8616. http://dx.doi.org/10.1074/jbc.M413541200.
61. Coban C, Ishii KJ, Kawai T, Hemmi H, Sato S, Uematsu S, Yamamoto M, Takeuchi O, Itagaki S, Kumar N, Horii T, Akira S. 2005. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 201:19-25. http://dx.doi.org/10.1084/jem.20041836.
62. Wu X, Gowda NM, Kumar S, Gowda DC. 2010. Protein-DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses. J. Immunol. 184:4338-4348. http://dx.doi.org/10.4049/jimmunol.0903824.
63. Jelkmann W. 2005. Effects of erythropoietin on brain function. Curr. Pharm. Biotechnol. 6:65-79. http://dx.doi.org/10.2174/1389201053167257.